Precocious and delayed neocortical synaptogenesis in fetal holoprosencephaly

Clinical Neuropathology

Volumn 32, Issue 4, 2013, Pages 255-268

  Sarnat Dr , Harvey B ^a   Flores Sarnat, Laura ^a  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Cortical maturation; Fetus; Holoprosencephaly; Precocious and delayed synaptogenesis; Synaptophysin

Indexed keywords

SYNAPTOPHYSIN;

ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EPILEPTOGENESIS; FETUS; FETUS DISEASE; GLIA; HIPPOCAMPUS; HISTOPATHOLOGY; HOLOPROSENCEPHALY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEOCORTEX; NEWBORN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS;

FETUS; HOLOPROSENCEPHALY; HUMANS; NEUROGENESIS; SYNAPSES;

EID: 84879139515     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NP300588     Document Type: Article

References (39)

1. Sarnat HB, Flores-Sarnat L, Trevenen CL. Synaptophysin immunoreactivity in the human hippocampus and neocortex from 6 to 41 weeks of gestation. J Neuropathol Exp Neurol. 2010; 69: 234-245.
2. Sarnat HB, Born DE. Synaptophysin immunocytochemistry with thermal intensification: a marker of terminal axonal maturation in the human fetal nervous system. Brain Dev. 1999; 21: 41-50.
3. Ulfig N, Setzer M, Neudörfer F, Saretzki U. Changing distribution patterns of synaptophysinimmunoreactive structures in the human dorsal striatum of the fetal brain. Anat Rec. 2000; 258: 198-209.
4. Sarnat HB, Auer RN, Flores-Sarnat L. Synaptogenesis in the fetal corpus striatum, globus pallidus and substantia nigra. Correlations with striosomes of Graybiel and dyskinesias in premature infants. J Child Neurol. 2012; 27. in press.
5. Sarnat HB, Flores-Sarnat L, Auer R. N. Sequence of synaptogenesis in the human fetal cerebellar system. Part 1. Guillain-Mollaret triangle (dentate- rubro-olivo-cerebellar circuit). Dev Neurosci. 2013. in press.
6. Sarnat HB, Flores-Sarnat L, Auer R. N. Sequence of synaptogenesis in the human fetal cerebellar system. Part 2. Pontine nuclei and cerebellar cortex. Dev Neurosci. 2013. in press.
7. Jahn R, Schiebler W, Ouimet C, Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci USA. 1985; 82: 4137-4141.
8. Wiedenmann B, Franke WW. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell. 1985; 41: 1017-1028.
9. Sarnat HB. Cerebral Dysgenesis. Embryology and Clinical Expression. New York, London, UK: Oxford University Press. 1992. pp 175-207.
10. Golden JA. Holoprosencephaly: a defect in brain patterning. J Neuropathol Exp Neurol. 1998; 57: 991-999.
11. Sarnat HB, Flores-Sarnat L. Neuropathologic research strategies in holoprosencephaly. J Child Neurol. 2001; 16: 918-931.
12. Siebert JR. Holoprosencephaly. In: Sarnat HB (ed). MedLink. San Diego: www.MedLink.com; 2012.
13. Matsunaga E, Shiota K. Holoprosencephaly in human embryos: epidemiologic studies of 150 cases. Teratology. 1977; 16: 261-272.
14. Bullen PJ, Rankin JM, Robson SC. Investigation of the epidemiology and prenatal diagnosis of holoprosencephaly in the North of England. Am J Obstet Gynecol. 2001; 184: 1256-1262.
15. McCabe MJ, Gaston-Massuet C, Tziaferi V, Gregory LC, Alatzoglou KS, Signore M, Puelles E, Gerrelli D, Farooqi IS, Raza J, Walker J, Kavanaugh SI, Tsai PS, Pitteloud N, Martinez-Barbera JP, Dattani MT. Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction. J Clin Endocrinol Metab. 2011; 96: E1709-E1718.
16. Sarnat HB. Microscopic criteria to determine gestational age of the fetal and neonatal brain. In: García JH (ed). Neuropathology: The Diagnostic Approach. St. Louis: Mosby-Yearbook; 1997. p. 529-540.
17. Lui JH, Hansen DV, Kriegstein AR. Development and evolution of the human neocortex. Cell. 2011; 146: 18-36.
18. Laure-Kamionowska M, Szymanska K, Taraszewska A, Ogonowska W, Klepacka T, Deregowski K. Pathological spectrum of cerebral cortex disturbances in human holoprosencephaly. Disturbances of cortical development in human holoprosencephaly. Folia Neuropathol. 2011; 49: 244. abstract.
19. Sarnat HB, Nochlin D, Born DE. Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in early human fetal nervous system. Brain Dev. 1998; 20: 88-94.
20. Ulfig N. Calcium-binding proteins in the human developing brain. Adv Anat Embryol Cell Biol 2002; 165(III-IX): 1-92.
21. Barinka F, Druga R, Marusic P, Krsek P, Zamecnik J. Calretinin immunoreactivity in focal cortical dysplasias and in non-malformed epileptic cortex. Epilepsy Res. 2010; 88: 76-86.
22. Marcorelles P, Laquerrière A, Adde-Michel C, Marret S, Saugier-Veber P, Beldjord C, Friocourt G. Evidence for tangential migration disturbances in human lissencephaly resulting from a defect in LIS1, DCX and ARX genes. Acta Neuropathol. 2010; 120: 503-515.
23. Sarnat HB, Flores-Sarnat L. Radial micro-columnar cortical architecture: maturational arrest or cortical dysgenesis? Pediatr Neurol. 2013. in press.
24. Blxümcke I, Beck H, Suter B, Hoffmann D, Födisch HJ, Wolf HK, Schramm J, Elger CE, Wiestler OD. An increase of hippocampal calretinin-immunoreactive neurons correlates with early febrile seizures in temporal lobe epilepsy. Acta Neuropathol. 1999; 97: 31-39.
25. Blümcke I, Beck H, Nitsch R, Eickhoff C, Scheffler B, Celio MR, Schramm J, Elger CE, Wolf HK, Wiestler OD. Preservation of calretinin-immunoreactive neurons in the hippocampus of epilepsy patients with Ammon's horn sclerosis. J Neuropathol Exp Neurol. 1996; 55: 329-341.
26. Sarnat HB. Molecular genetic classification of central nervous system malformations. J Child Neurol. 2000; 15: 675-687. CrossRef
27. Flores-Sarnat L, Sarnat HB. Axes and gradients of the neural tube and other criteria for an integrated morphological and molecular genetic classification of nervous system malformations. In: Sarnat HB, Curatolo P (eds). Malformations of the Nervous System. Edinburgh, London, NY, Toronto: Elsevier; 2008. p. 87; 3-11.
28. Bauer R, Zubler F, Hauri A, Muir DR, Douglas RJ. Developmental origin of patchy axonal connectivity in the neocortex: a computational model. Cereb Cortex. 2012; in press. e-pub ahead of print, doi:10:1093/cercor/bhs327.
29. Aoto K, Shikata Y, Higashiyama D, Shiota K, Motoyama J. Fetal ethanol exposure activates protein kinase-A and impairs Shh expression in prechordal mesoderm cells in the pathogenesis of holoprosencephaly. Birth Defects Res A Clin Mol Teratol. 2008; 82: 224-231. CrossRefPart A
30. Plawner LL, Delgado MR, Miller VS, Levey EB, Kinsman SL, Barkovich AJ, Simon EM, Clegg NJ, Sweet VT, Stashinko EE, Hahn JS. Neuroanatomy of holoprosencephaly as predictor of function: beyond the face predicting the brain. Neurology. 2002; 59: 1058-1066.
31. Hahn JS, Pinter JD. Holoprosencephaly: genetic, neuroradiological, and clinical advances. Semin Pediatr Neurol. 2002; 9: 309-319.
32. Hahn JS. Midline hypoplasias. Holoprosencephaly. In: Sarnat HB, Curatolo P (eds). Handbook of Clinical Neurology, Vol. 87 (3rd series). Edinburgh: Elsevier; 2008. p. 13-37.
33. Hahn JS, Delgado MR, Clegg NJ, Sparagana SP, Gerace KL, Barkovich AJ, Olson DM. Electroencephalography in holoprosencephaly: findings in children without epilepsy. Clin Neurophysiol. 2003; 114: 1908-1917.
34. Painter MJ, Sun Q, Scher MS, Janosky J, Alvin J. Neonates with seizures: what predicts development?. J Child Neurol. 2012; 27: 1022-1026.
35. Hori A. Precocious cerebral development associated with agenesis of the corpus callosum in midfetal life: a transient syndrome?. Acta Neuropathol. 1996; 91: 120-125.
36. Sarnat HB. Role of human fetal ependyma. Pediatr Neurol. 1992; 8: 163-178.
37. Sarnat HB. Regional differentiation of the human fetal ependyma: immunocytochemical markers. J Neuropathol Exp Neurol. 1992; 51: 58-75.
38. Nakamura R, Kurita K, Kawanami T, Kato T. An immunohistochemical study of Purkinje cells in a case of hereditary cerebellar cortical atrophy. Acta Neuropathol. 1999; 97: 196-200.
39. Barth PG, Aronica E, de Vries L, Nikkels PG, Scheper W, Hoozemans JJ, Poll-The BT, Troost D. Pontocerebellar hypoplasia type 2: a neuropathological update. Acta Neuropathol. 2007; 114: 373-386.